Alzheimer’s Association International Conference® | July 14-18, 2019 | Los Angeles, USA
The schedule below reflects the invited program only. The complete schedule, including the submitted program, will be available closer to the conference.
Association Welcome
Session: PL-01-01
Understanding the Earliest Phases of Alzheimer’s Disease
Marilyn Albert
Johns Hopkins University School of Medicine, USA
Theme: Therapeutics
Session: PL-01-02
Sleep, Brain and Cognition
Ruth M. Benca
University of California, Irvine, USA
Theme: Therapeutics
Session: PL-02-01
Alzheimer’s Disease Blood-Based Biomarkers and AD Control
SangYun Kim
Seoul National University, South Korea
Theme: Diagnosis and Prognosis
Session: PL-02-02
Inge Grundke-Iqbal Award for Alzheimer’s Research: Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia
Shane A. Liddelow, Ph.D.
NYU School of Medicine, USA
Theme: Basic and Translational Science
Session: PL-03-01
The Epidemiology of Diversity and Dementia
Rachel Whitmer
University of California, Davis, USA
Theme: Public Health and Psychosocial
Session: PL-03-02
Imaging Neurodegeneration With MRI: What Is New?
David Wolk
University of Pennsylvania Memory Center, USA
Theme: Diagnosis and Prognosis
Session: PL-04-01
The Cellular Phase of Alzheimer’s Disease
Bart De Strooper
University College London, United Kingdom; University of Leuven, Belgium
Theme: Basic and Translational Science
Session: PL-04-02
Microglia in Neurodegenerative Conditions
Marco Colonna
Washington University in St. Louis, USA
Theme: Basic and Translational Science
Session: PL-05-01
Precision Medicine, Population Neuroscience and Comprehensive Care: Partners to Develop and Deliver Effective Prevention and Treatments for Dementia
Sudha Seshadri
The University of Texas Health Science Center at San Antonio, USA
Theme: Public Health & Psychosocial
Session: PL-05-02
Symposium Sessions
-
Disparities in Access to Dementia Care and Prevention [S1-01]
8 - 9:30 a.m.
Theme: Public Health and Psychosocial
Dementia Prevention Programs in Urban and Regional Aboriginal Communities in Australia [S1-01-01]
Kylie Radford
University of New South Wales, Australia
Effects of Health Literacy on Access to Dementia Care [S1-01-02]
Jennifer Lingler
University of Pittsburgh, USA
Improving the Lives of People with Dementia - The OECD Perspective [S1-01-03]
Elina Suzuki
Organization for Economic Co-operation and Development, France
Dementia As Access Barrier in Palliative Care [S1-01-04]
Li Gang
University of Pittsburgh, USA
-
“Rare Variants” And Their Role In Genetic Etiology And Disease [S1-02]
8 - 9:30 a.m.
Theme: Basic and Translational Science
Analysis of Predicted Loss-of-Function Variants in UK Biobank Identifies Variants Protective for Disease [S1-02-01]
Whole Genome Sequencing and Imputation in Isolated Populations Identify Genetic Associations with Medically-Relevant Complex Traits [S1-02-02]
Population-Specific Genetic Variation in Large Sequencing Data Sets: Why More Data Is Still Better [S1-02-03]
High-Throughput SNP-Seq to Identify Noncoding Functional SNPs [S1-02-04]
-
PET and CSF Markers of Neuroinflammation [S2-01]
8 - 9:30 a.m.
Theme: Diagnosis and Prognosis
PET Markers of Microglia [S2-01-01]
Robert Innis
National Institute of Mental Health, USA
PET Markers of Astrocytes [S2-01-02]
Elena Rodriguez-Vieitez
Karolinska Institute, Sweden
Neuroinflammation: CSF Perspective [S2-01-03]
Fluid Biomarkers of Neuroinflammation [S2-01-04]
Charlotte Teunissen
VU University Medical Center, Netherlands
-
Precision Medicine [S2-02]
8 - 9:30 a.m.
Theme: Therapeutics
Precision Medicine Model for Targeted NSAID Therapy in AD [S2-02-01]
Sid O'Bryant
University of North Texas Health Science Center, USA
Michael Heneka
German Center for Neurodegenerative Diseases (DZNE), Germany
Insulin-Resistant Sub-Typing [S2-02-03]
Suzanne Craft
Wake Forest School of Medicine, USA
Subtyping of Clinical Subjects through Exosome Analyses [S2-02-04]
Dimitrios Kapogiannis
National Institute on Aging/National Institutes of Health (NIA/NIH), USA
-
Overlapping AD Pathologies and their Influence on Disease Phenotypes [S3-01]
8 - 9:30 a.m.
Theme: Diagnosis and Prognosis
Alzheimer’s and Vascular Disease: Pathologic Perspective [S3-01-01]
Costantino Iadecola
Weill Cornell Medicine, USA
Alzheimer’s Disease and Subcortical Vascular Cognitive Impairment (SVCI): Biomarker Perspective [S3-01-02]
Duk Na
Samsung Medical Center, Korea, Republic of Korea (South)
Alzheimer’s and Lewy Body Disease: Pathologic Perspective [S3-01-03]
David Irwin
University of Pennsylvania, USA
Alzheimer’s and Lewy Body Disease: Biomarker Perspective [S3-01-04]
-
Responder Analyses Leading to Hypothesis Generation for Prospective Study Designs [S3-02]
8 - 9:30 a.m.
Theme: Therapeutics
Suzanne Hendrix
Pentara Corporation, USA
Multi-Crossover Randomized Control Design Approaches Based on Analyses of Responder/Non-Responder Outcomes [S3-02-02]
Steven Arnold Massachusetts General Hospital, USA; Harvard Medical School, USA
To be announced.
To be announced. [S3-02-03]
To be announced. [S3-02-04]
Eric Siemers
Cogstate, Ltd., USA
-
National Dementia Registries: Quality Control and Recruitment of Research Participants [S4-01]
8 - 9:30 a.m.
Theme: Public Health and Psychosocial
The Brain Health Registry for Recruitment of Research Participants: 5 Year Experience [S4-01-01]
Michael Weiner
University of California, San Francisco, USA
The Dutch Brain Health Registry for Recruitment of Research Participants [S4-01-02]
Marissa Zwan
VU University Medical Center, Netherlands
Swedish Clinical Quality Registry for Dementia [S4-01-03]
Dorota Religa
Karolinska Institute, Sweden
Australian Clinical Quality Registry for Dementia [S4-01-04]
Stephanie Ward
Monash University, Australia
-
Delirium in Dementia: A Translational Aspect [S5-01]
8:30 - 10 a.m.
Theme: Basic and Translational Science
Description and Impact of Delirium on Dementia [S5-01-01]
Daniel Davis
University College London, United Kingdom
Biomarkers in Delirium [S5-01-02]
Neurobiology of Delirium and Its Intersection with Dementia: Insights from Animal Models [S5-01-03]
Colm Cunningham
Trinity College Dublin, Ireland
Systemic Inflammation Signaling to the Brain [S5-01-04]
Roosmarijn Vandenbroucke
Ghent University, Belgium
Become an ISTAART Member
Members of this professional society stay connected to the field through exclusive member benefits and programs. Join for just $30* at the Alzheimer's Association (Booth 500).
*Offer available onsite at AAIC (through 7/18/19). Applies only to registrants who paid the non-member fee.
join today
Join the Conversation #AAIC19
> 1200px
lg
> 992px
md
> 768px
sm
< 767px
xs
Join the Conversation #AAIC19